KLK3 and posterior cortical atrophy: By developing a non-invasive method that is independent of PSA, such as the FLNA diagnostics described here, the rate of unnecessary biopsies may be reduced and the risk of aggressive PCa detection can be determined to allow healthcare providers to make an informed decision to pursue biopsies.